These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 8305775)

  • 1. Fluvoxamine-associated manic behavior: a case series.
    Dorevitch A; Frankel Y; Bar-Halperin A; Aronzon R; Zilberman L
    Ann Pharmacother; 1993 Dec; 27(12):1455-7. PubMed ID: 8305775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Manic-switch induced by fluvoxamine in abstinent pure methamphetamine abusers.
    Won M; Minabe Y; Sekine Y; Takei N; Kondo N; Mori N
    J Psychiatry Neurosci; 2003 Mar; 28(2):134-5. PubMed ID: 12670131
    [No Abstract]   [Full Text] [Related]  

  • 3. [Fluvoxamine. Study of treatment effect on a group of 189 hospitalized patients with depression].
    Peyre F; Verdoux H; Bourgeois M
    Encephale; 1992 Jan; 18 Spec No 1():73-4. PubMed ID: 1600911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Alpha-interferon and mental disorders].
    Debien C; De Chouly De Lenclave MB; Foutrein P; Bailly D
    Encephale; 2001; 27(4):308-17. PubMed ID: 11686052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A display of hypomania in a depressed male in response to fluvoxamine.
    Horiguchi T; Sai S
    World J Biol Psychiatry; 2001 Oct; 2(4):201-4. PubMed ID: 12587152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluvoxamine induced oculogyric dystonia and manic switch in a patient with obsessive compulsive disorder.
    Tikka SK; Garg S; Das B
    Indian J Pharmacol; 2013; 45(5):532-3. PubMed ID: 24130396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restlessness related to SSRI withdrawal.
    Hirose S
    Psychiatry Clin Neurosci; 2001 Feb; 55(1):79-80. PubMed ID: 11235863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy of fluvoxamine in obsessive-compulsive disorder: effects of comorbid chronic tic disorder.
    McDougle CJ; Goodman WK; Leckman JF; Barr LC; Heninger GR; Price LH
    J Clin Psychopharmacol; 1993 Oct; 13(5):354-8. PubMed ID: 8227493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluvoxamine-associated sexual dysfunction.
    Dorevitch A; Davis H
    Ann Pharmacother; 1994; 28(7-8):872-4. PubMed ID: 7949503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotonin syndrome-like symptoms in a patient with obsessive-compulsive disorder, following inappropriate increase in fluvoxamine dosage.
    Lenzi A; Raffaelli S; Marazziti D
    Pharmacopsychiatry; 1993 May; 26(3):100-1. PubMed ID: 8415895
    [No Abstract]   [Full Text] [Related]  

  • 11. Fluvoxamine pharmacotherapy of anxiety disorders in later life: preliminary open-trial data.
    Wylie ME; Miller MD; Shear MK; Little JT; Mulsant BH; Pollock BG; Reynolds CF
    J Geriatr Psychiatry Neurol; 2000; 13(1):43-8. PubMed ID: 10753007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concentration-response relationship for fluvoxamine using remission as an endpoint: a receiver operating characteristics curve analysis in major depression.
    Suzuki Y; Fukui N; Sawamura K; Sugai T; Watanabe J; Ono S; Inoue Y; Ozdemir V; Someya T
    J Clin Psychopharmacol; 2008 Jun; 28(3):325-8. PubMed ID: 18480690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Manic behaviors associated with fluoxetine in three 12- to 18-year-olds with obsessive-compulsive disorder.
    Go FS; Malley EE; Birmaher B; Rosenberg DR
    J Child Adolesc Psychopharmacol; 1998; 8(1):73-80. PubMed ID: 9639082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A controlled trial of lithium augmentation in fluvoxamine-refractory obsessive-compulsive disorder: lack of efficacy.
    McDougle CJ; Price LH; Goodman WK; Charney DS; Heninger GR
    J Clin Psychopharmacol; 1991 Jun; 11(3):175-84. PubMed ID: 1820757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seizure possibly associated with fluvoxamine.
    Kim KY; Craig JM; Hawley JM
    Ann Pharmacother; 2000 Nov; 34(11):1276-8. PubMed ID: 11098342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluvoxamine-associated mania/hypomania in patients with obsessive-compulsive disorder.
    Jefferson JW; Greist JH; Perse TL; Rosenfeld R
    J Clin Psychopharmacol; 1991 Dec; 11(6):391-2. PubMed ID: 1770160
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficacy of fluvoxamine in treatment-refractory depression.
    Delgado PL; Price LH; Charney DS; Heninger GR
    J Affect Disord; 1988; 15(1):55-60. PubMed ID: 2970493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluvoxamine withdrawal syndrome.
    Szabadi E
    Br J Psychiatry; 1992 Feb; 160():283-4. PubMed ID: 1540778
    [No Abstract]   [Full Text] [Related]  

  • 19. [Carbamazepine-fluvoxamine interaction. Consequences for the carbamazepine plasma level].
    Cottencin O; Regnaut N; Thévenon-Gignac C; Thomas P; Goudemand M; Debruille C; Robert H
    Encephale; 1995; 21(2):141-5. PubMed ID: 7781585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluvoxamine: a review of the controlled trials in depression.
    Ware MR
    J Clin Psychiatry; 1997; 58 Suppl 5():15-23. PubMed ID: 9184623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.